Send Inquiry

Request To Call Back

Adcetris 50 mg Infusion

Name: Adcetris 50 mg Infusion
Brand: K. K. PHARMA SOLUTIONS
Price: 204922.0 INR
Availability: InStock

Price 204922.0 INR/ Perch

Get a Price/Quote

MOQ : 10 Pieces

Adcetris 50 mg Infusion Specification

Brand Name
Adcetris

Packaging Type
Vial

Salt Composition
Brentuximab Vedotin 50 mg

Indication
Relapsed or refractory Hodgkin lymphoma, relapsed or refractory systemic anaplastic large cell lymphoma

Pacakaging (Quantity Per Box)
1 vial per box

Dosage Form
Infusion

Life Span
24 months from manufacturing

Origin of Medicine
Imported

Drug Type
Prescription Only

Ingredients
Brentuximab Vedotin

Physical Form
Lyophilized Powder for Solution for Infusion

Function
Antineoplastic/Antibody-Drug Conjugate

Recommended For
Hodgkin Lymphoma, Systemic Anaplastic Large Cell Lymphoma

Dosage
As directed by physician, typically 1.8 mg/kg every 3 weeks

Dosage Guidelines
Reconstitute prior to administration. Administer as intravenous infusion over 30 minutes. Do not administer as IV push or bolus.

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store at 2C-8C (Refrigerate). Do not freeze.

NDC Code
51144-050-01

Common Side Effects
Peripheral neuropathy, neutropenia, nausea, fatigue, anemia

ATC Code
L01XC12

Caution
Use with caution in patients with hepatic or renal impairment

Reconstitution Instructions
Reconstitute with 10.5 mL of sterile water for injection

Patient Counselling Information
Inform patients of potential side effects and infusion reactions

Administration Route
Intravenous

Preservative
No preservative

Contraindications
Hypersensitivity to Brentuximab Vedotin or excipients

Batch/Expiry Information
Printed on vial and carton

Appearance after Reconstitution
Clear to slightly opalescent, colorless solution

Maximum Dose
Do not exceed 1.8 mg/kg per dose

Adcetris 50 mg Infusion Trade Information

Minimum Order Quantity
10 Pieces

Supply Ability
100 Pieces Per Month

Delivery Time
7 Days

About Adcetris 50 mg Infusion

Adcetris 50 mg Infusion is a rare and distinguished antineoplastic solution, renowned for its favorable reviews among medical professionals. Laureate for its efficacy, it is therapeutically perfect for adults with relapsed or refractory Hodgkin lymphoma or systemic anaplastic large cell lymphoma. Its highlighted active ingredient, Brentuximab Vedotin, is supplied as a lyophilized powder, reconstituted into a clear, colorless solution for intravenous infusion. Manufactured to the highest standards, each imported vial assures consistent quality and safety, meeting precise dosage and storage requirements for optimal patient outcomes.

Specific Use, Application Method and Other Features of Adcetris 50 mg Infusion

Adcetris 50 mg Infusion is specifically recommended for adults diagnosed with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Its innovative formulation ensures targeted antineoplastic activity. The therapy is precisely administered as an intravenous infusion over 30 minutes, after reconstitution with 10.5 mL of sterile water. Notably, it does not contain preservatives and is supplied as a single vial per box, stored refrigerated at 2C to 8C. Usage is strictly under a physician's direction.

Payment Terms, Packaging, and Certification Details for Adcetris 50 mg Infusion

The list price and valuation for Adcetris 50 mg Infusion reflect its premium quality and rare therapeutic value. The product is quick to dispatch, ensuring timely delivery for critical medical needs. Each infusion is packaged in a secure vial, with packaging details and expiry information printed for traceability. This prescription-only drug is imported and meets distinguished certifications, making it a trusted choice for exporters, suppliers, and traders in India.

FAQ's of Adcetris 50 mg Infusion:

Q: How is Adcetris 50 mg Infusion administered to patients?

A: The infusion is reconstituted with 10.5 mL of sterile water, then administered intravenously over 30 minutes by a healthcare professional. It must not be given as a rapid IV push or bolus.

Q: What are the primary indications for using Adcetris 50 mg Infusion?

A: Adcetris is primarily indicated for adults with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma, as directed by a physician.

Q: What precautions should be taken before starting Adcetris 50 mg Infusion?

A: Patients should be evaluated for hypersensitivity to Brentuximab Vedotin or its excipients. Caution is advised if the patient has hepatic or renal impairment, and all potential side effects should be discussed beforehand.

Q: When should a patient avoid using Adcetris 50 mg Infusion?

A: Patients with known hypersensitivity to Brentuximab Vedotin or any components of this medication should not use Adcetris. Consult your physician for further clarification.

Q: What are the most common side effects associated with Adcetris 50 mg Infusion?

A: Common side effects include peripheral neuropathy, neutropenia, nausea, fatigue, and anemia. Patients should be monitored regularly for these adverse reactions.